Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Q2 2024 Earnings Call Transcript : Comparemela.com

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Q2 2024 Earnings Call Transcript

Card image cap

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Q2 2024 Earnings Call Transcript

insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

United States , America , American , Eli Lilly , Ken Myszkowski , Ellie Merle , Edward Tenthoff , Mayank Mamtani , Cardiometabolic Webinar , James Hamilton , Maury Raycroft , Jason Gerberry , Chris Anzalone , Vince Anzalone , Piper Sandler , Arrowhead Pharmaceuticals Conference Call , Novartis , American Thoracic Society , International Conference On Antiviral Research , European Atherosclerosis Society , Nasdaq , International Conference , National Lipid Association Scientific Sessions , Securities Exchange , Arrowhead Pharmaceuticals Inc , Amgen , European Atherosclerosis Society Congress , Arrowhead Pharmaceuticals , Call Transcript May , Arrowhead Pharmaceuticals Conference , Vice President , Investor Relations , Bruce Given , Interim Chief Medical Scientist , Translational Medicine , Chief Financial Officer , Securities Act , Securities Exchange Act , Summer Series , Muscle Vertical Day , Cardiometabolic Day , Pulmonary Day , Metabolic Disease Day , Antiviral Research , National Lipid Association Scientific , Royalty Pharma , Outcomes Trial , Metabolic Rd Webinar , Advanced Glycation End , Luca Issi , Grain Exporting Countries ,

comparemela.com © 2020. All Rights Reserved.